Nada Salem, Chemistry editor The race to develop vaccines for COVID-19 marks the beginning of a new chapter in medicine: one where we have solutions for previously incurable diseases, more precise therapies, and phenomenally faster drug development. New frontiers in ribonucleic acid (RNA) medicine play a prominent role in this development. Ribonucleic acid is a […]
vaccine development
Why are some Canadians hesitant about COVID-19 vaccines?
Michael Ralph Limmena, Health, Medicine and Veterinary Sciences editor In the wake of the Canadian government’s approval of the Pfizer-BioNTech and Moderna COVID-19 vaccines in December 2020, many Canadians are eager to get vaccinated. However, some people remain hesitant. According to an IPSOS survey of 1,001 Canadians in November 2020, 28 per cent would […]
Adapting to change: The challenge of HIV vaccine development
by Emerson Gaglardi, New Science Communicator In 2016, 36.7 million people around the world were living with HIV (human immunodeficiency virus) infections. To put this in perspective, that is about the same as the current population of Canada. Without treatment, HIV dramatically reduces the number of infection-fighting white blood cells over a period of about […]